Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Clinical trial NCT02356653 · RECRUITING

Trial details

NCT number: NCT02356653
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Leukemia Inborn Errors of Metabolism Bone Marrow Failure Syndromes Immunodeficiencies Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome

Start date: 2013-12-01
Primary completion: 2027-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.